Osteoarthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with knee osteoarthritis (a condition where the knee joint breaks down over time), confirmed by a doctor using X-rays or MRI scans showing specific signs of joint damage.
- Adults between the ages of 40 and 75 years.
- People who are willing to give their consent to take part and are able to attend all treatment sessions and follow-up appointments as required by the study.
- People whose knee osteoarthritis is rated as mild to moderate (grades 1 to 3 on a standard medical scale called the Kellgren-Lawrence scale).
Who may not be able to join:
- People who currently have or have been diagnosed with cancer (active malignancy).
- People with a history of epilepsy.
- People who have a condition that makes their skin sensitive to light (photosensitivity disorder).
- People who have an active infection in or around the knee area being treated.
- People who have had knee surgery in the past 6 months.
- People who have knee surgery planned during the period the study is running.
- People whose knee osteoarthritis is rated as severe (grade 4 on the Kellgren-Lawrence scale), where a doctor would typically recommend surgery.
- Women who are pregnant or currently breastfeeding.
- People with uncontrolled diabetes.
- People with severe heart or cardiovascular disease.
- People with neurological conditions (disorders affecting the brain or nerves) that could interfere with taking part in the study or affect results (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ahmed Bapir, PhD, EPU
Phone: +9647504631542
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Pain Intensity (WOMAC Pain Subscale)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.